Jason Fox Named Director, Evonik Oil & Gas Group
Brings Decade Of Oilfield Chemicals Experience To Position
Evonik Corporation has appointed Jason Fox as director of Evonik’s Oil & Gas Group, which the company formed to boost the resource-efficiency of products it supplies to the oil and gas industries.
"I am very happy to welcome an experienced professional such as Jason to Evonik’s Oil & Gas Group,” said Ted Pettijohn, senior vice president of growth and development at Evonik. “Global demand for energy is projected to rise with oil and natural gas becoming the top two energy resources. A tremendous amount of investment and advances in technology will be required to meet these demands. Jason’s role will be to develop and execute Evonik’s strategy to leverage our products and technology to support these industries.”
Fox joins Evonik after more than 10 years at oilfield chemicals company Nalco Champion. Fox supported the company in various roles including marketing, business development, strategic market planning, and pricing management.
“Joining Evonik’s Oil & Gas Group is a tremendous opportunity that I’m very excited about,” Fox said. “Projected trends in the energy industry indicate many opportunities for Evonik’s Oil & Gas Group to facilitate the company’s global growth within this expanding and evolving market. The demand for chemicals and innovation within this sector is rapidly growing and, as one of the world’s leading specialty chemicals companies, we can meet these needs.”
Fox earned a Bachelor of Arts from the University of Calgary and a Master of Business Administration from Athabasca University in Canada.
For additional information about Evonik in North America, please visit our website: www.evonik.com/north-america. Please visit us on Facebook at www.facebook.com/EvonikNorthAmerica. Follow us on Twitter at http://twitter.com/EvonikN_America.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2012 more than 33,000 employees generated sales of around €13.4 billion and an operating profit (adjusted EBITDA) of about €2.4 billion (excluding Real Estate in both cases).
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.